Clinical Trials Directory

Trials / Completed

CompletedNCT05535231

A Study to Evaluate the Effect of Turmeric in Healthy Participants

A Randomized, Double-Blinded, Comparator-Controlled, Crossover Study to Evaluate the Pharmacokinetics of Gaia Full-Spectrum Turmeric Phytocapsules

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Gaia Herbs Inc. · Industry
Sex
All
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

Turmeric is recognized as a bioactive compound with potential benefits for human health. This study compares the pharmacokinetic profile of the Turmeric test product to a comparator.

Detailed description

This randomized, double-blinded, comparator-controlled, crossover study will compare the pharmacokinetic profile of the Turmeric test product to a comparator.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTurmeric test product2 capsules of 490 mg Turmeric are taken with water once
DIETARY_SUPPLEMENTTurmeric comparator2 capsules of 200 mg Turmeric are taken with water once

Timeline

Start date
2022-09-24
Primary completion
2022-10-03
Completion
2022-10-03
First posted
2022-09-10
Last updated
2023-02-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05535231. Inclusion in this directory is not an endorsement.

A Study to Evaluate the Effect of Turmeric in Healthy Participants (NCT05535231) · Clinical Trials Directory